Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.
$143.42 +6.05 (4.40%)
As of 03/05/2021 15:59:56 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.